Development of SARS-CoV-2 infection in patients with rheumatic conditions on hydroxychloroquine monotherapy vs. patients without rheumatic conditions: a retrospective, propensity-matched cohort study

DOI record: { "DOI": "10.1016/j.amjms.2022.08.006", "ISSN": [ "0002-9629" ], "URL": "http://dx.doi.org/10.1016/j.amjms.2022.08.006", "alternative-id": [ "S0002962922003482" ], "assertion": [ { "label": "This article is maintained by", "name": "publisher", "value": "Elsevier" }, { "label": "Article Title", "name": "articletitle", "value": "Development of SARS-CoV-2 infection in patients with rheumatic conditions on hydroxychloroquine monotherapy vs. patients without rheumatic conditions: a retrospective, propensity-matched cohort study" }, { "label": "Journal Title", "name": "journaltitle", "value": "The American Journal of the Medical Sciences" }, { "label": "CrossRef DOI link to publisher maintained version", "name": "articlelink", "value": "https://doi.org/10.1016/j.amjms.2022.08.006" }, { "label": "Content Type", "name": "content_type", "value": "article" }, { "label": "Copyright", "name": "copyright", "value": "© 2022 Published by Elsevier Inc. on behalf of Southern Society for Clinical Investigation." } ], "author": [ { "affiliation": [], "family": "Gentry", "given": "Chris A.", "sequence": "first" }, { "affiliation": [], "family": "Thind", "given": "Sharanjeet K.", "sequence": "additional" }, { "affiliation": [], "family": "Williams", "given": "Riley J.", "sequence": "additional", "suffix": "II" }, { "affiliation": [], "family": "Hendrickson", "given": "Sage C.", "sequence": "additional" }, { "affiliation": [], "family": "Kurdgelashvili", "given": "George", "sequence": "additional" }, { "affiliation": [], "family": "Humphrey", "given": "Mary Beth", "sequence": "additional" } ], "container-title": "The American Journal of the Medical Sciences", "container-title-short": "The American Journal of the Medical Sciences", "content-domain": { "crossmark-restriction": true, "domain": [ "clinicalkey.fr", "clinicalkey.jp", "clinicalkey.com.au", "clinicalkey.es", "amjmedsci.org", "clinicalkey.com", "elsevier.com", "sciencedirect.com" ] }, "created": { "date-parts": [ [ 2022, 9, 11 ] ], "date-time": "2022-09-11T13:32:07Z", "timestamp": 1662903127000 }, "deposited": { "date-parts": [ [ 2022, 9, 11 ] ], "date-time": "2022-09-11T13:32:21Z", "timestamp": 1662903141000 }, "indexed": { "date-parts": [ [ 2022, 9, 11 ] ], "date-time": "2022-09-11T14:13:58Z", "timestamp": 1662905638811 }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2022, 9 ] ] }, "language": "en", "license": [ { "URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2022, 9, 1 ] ], "date-time": "2022-09-01T00:00:00Z", "timestamp": 1661990400000 } } ], "link": [ { "URL": "https://api.elsevier.com/content/article/PII:S0002962922003482?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "https://api.elsevier.com/content/article/PII:S0002962922003482?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining" } ], "member": "78", "original-title": [], "prefix": "10.1016", "published": { "date-parts": [ [ 2022, 9 ] ] }, "published-print": { "date-parts": [ [ 2022, 9 ] ] }, "publisher": "Elsevier BV", "reference": [ { "article-title": "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges", "author": "Lai", "journal-title": "Int J Antimicrobe Agents", "key": "10.1016/j.amjms.2022.08.006_bib0001", "volume": "55", "year": "2020" }, { "DOI": "10.1038/s41422-020-0282-0", "article-title": "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro", "author": "Wang", "doi-asserted-by": "crossref", "first-page": "269", "journal-title": "Cell Res", "key": "10.1016/j.amjms.2022.08.006_bib0002", "volume": "30", "year": "2020" }, { "DOI": "10.1093/cid/ciaa237", "article-title": "In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2)", "author": "Yao", "doi-asserted-by": "crossref", "first-page": "732", "journal-title": "Clin Infect Dis", "key": "10.1016/j.amjms.2022.08.006_bib0003", "volume": "28", "year": "2020" }, { "DOI": "10.1093/jac/dkaa403", "article-title": "Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis", "author": "Kashour", "doi-asserted-by": "crossref", "first-page": "30", "journal-title": "J Antimicrob Chemother", "key": "10.1016/j.amjms.2022.08.006_bib0004", "volume": "76", "year": "2021" }, { "DOI": "10.1016/j.cmi.2020.08.022", "article-title": "Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis", "author": "Fiolet", "doi-asserted-by": "crossref", "first-page": "19", "journal-title": "Clin Microbiol Infect", "key": "10.1016/j.amjms.2022.08.006_bib0005", "volume": "27", "year": "2021" }, { "article-title": "Serious cardiovascular adverse events associated with hydroxychloroquine/chloroquine alone or with azithromycin in patients with COVID-19: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS)", "author": "Zhao", "journal-title": "Advance online publication", "key": "10.1016/j.amjms.2022.08.006_bib0006", "year": "2022" }, { "DOI": "10.1056/NEJMoa2016638", "article-title": "A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19", "author": "Boulware", "doi-asserted-by": "crossref", "first-page": "517", "journal-title": "N Engl J Med", "key": "10.1016/j.amjms.2022.08.006_bib0007", "volume": "383", "year": "2020" }, { "DOI": "10.7326/M20-6519", "article-title": "Hydroxychloroquine as postexposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 infection", "author": "Barnabas", "doi-asserted-by": "crossref", "first-page": "344", "journal-title": "Ann Intern Med", "key": "10.1016/j.amjms.2022.08.006_bib0008", "volume": "174", "year": "2021" }, { "DOI": "10.1056/NEJMoa2021801", "article-title": "A cluster-randomized trial of hydroxychloroquine for prevention of Covid-19", "author": "Mitja", "doi-asserted-by": "crossref", "first-page": "417", "journal-title": "N Engl J Med", "key": "10.1016/j.amjms.2022.08.006_bib0009", "volume": "384", "year": "2021" }, { "DOI": "10.1001/jamainternmed.2020.6319", "article-title": "Efficacy and safety of hydroxychloroquine vs placebo for pre-exposure SARS-CoV-2 prophylaxis among health care workers", "author": "Abella", "doi-asserted-by": "crossref", "first-page": "195", "journal-title": "JAMA Intern Med", "key": "10.1016/j.amjms.2022.08.006_bib0010", "volume": "181", "year": "2021" }, { "DOI": "10.1093/cid/ciaa1571", "article-title": "Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial", "author": "Rajasingham", "doi-asserted-by": "crossref", "first-page": "e835", "journal-title": "Clin Infect Dis", "key": "10.1016/j.amjms.2022.08.006_bib0011", "volume": "72", "year": "2021" }, { "DOI": "10.1007/s40121-020-00325-2", "article-title": "The pharmacokinetic and pharmacodynamic properties of hydroxychloroquine and dose selection for COVID-19: putting the cart before the horse", "author": "Morrisette", "doi-asserted-by": "crossref", "first-page": "561", "journal-title": "Infect Dis Ther", "key": "10.1016/j.amjms.2022.08.006_bib0012", "volume": "9", "year": "2020" }, { "DOI": "10.1016/S2665-9913(20)30305-2", "article-title": "Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study", "author": "Gentry", "doi-asserted-by": "crossref", "first-page": "e689", "journal-title": "Lancet Rheumatol", "key": "10.1016/j.amjms.2022.08.006_bib0013", "volume": "2", "year": "2020" }, { "DOI": "10.1056/NEJMoa2012410", "article-title": "Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19", "author": "Geleris", "doi-asserted-by": "crossref", "first-page": "2411", "journal-title": "N Engl J Med", "key": "10.1016/j.amjms.2022.08.006_bib0014", "volume": "382", "year": "2020" }, { "DOI": "10.1136/bmj.m1844", "article-title": "Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data", "author": "Mahevas", "doi-asserted-by": "crossref", "first-page": "m1844", "journal-title": "BMJ", "key": "10.1016/j.amjms.2022.08.006_bib0015", "volume": "369", "year": "2020" }, { "DOI": "10.1001/jama.2020.8630", "article-title": "Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State", "author": "Rosenberg", "doi-asserted-by": "crossref", "first-page": "2493", "journal-title": "JAMA", "key": "10.1016/j.amjms.2022.08.006_bib0016", "volume": "323", "year": "2020" }, { "DOI": "10.5582/bst.2020.01047", "article-title": "Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies", "author": "Goa", "doi-asserted-by": "crossref", "first-page": "72", "journal-title": "Biosci Trends", "key": "10.1016/j.amjms.2022.08.006_bib0017", "volume": "14", "year": "2020" }, { "article-title": "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial", "author": "Gautret", "issue": "1", "journal-title": "Int J Antimicrob Agents. Int J Antimicrob Agents", "key": "10.1016/j.amjms.2022.08.006_bib0018", "volume": "56", "year": "2020" } ], "reference-count": 18, "references-count": 18, "relation": {}, "resource": { "primary": { "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0002962922003482" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "General Medicine" ], "subtitle": [], "title": "Development of SARS-CoV-2 infection in patients with rheumatic conditions on hydroxychloroquine monotherapy vs. patients without rheumatic conditions: a retrospective, propensity-matched cohort study", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy" }